(March 11, 2017) WASHINGTON, DC  – “President Donald Trump’s nomination of Dr. Scott Gottlieb to lead the Food and Drug Administration signals he is serious about increasing access to safe, effective and affordable medicines for Americans while taking a market based, competitive approach towards lowering drug costs. Dr. Gottlieb is one of the most formidable thought leaders in the medical field and makes an excellent choice to lead the agency responsible for ensuring the public health of the millions of patients FDA serves.

AAM Applauds Nomination of Dr. Scott Gottlieb to Lead the Food and Drug Administration